|Last Price$42.95||Day Change (%)1.08%|
|Open Price$42.98||Day Change ($)0.46|
|Day Range41.82–43.53||52-Week Range12.63–45.36|
As of Mon 4/20/2015 5:00:00 PM | USD
Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets
On Monday, Neurocrine Biosciences NBIX accelerated its anticipated filing date for indiplon capsules to the second quarter of 2007 instead of 2009. We're placing Neurocrine under review while we revisit our assumptions, and because DOV Pharmaceutical DOVP is entitled to a royalty on any indiplon ...